OnKure Therapeutics, Inc.
OKURNasdaqCIK 1637715HealthcareFiscal year ends Dec 31
Reports and events: 100 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1322:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-347315 |
| 2026-08-0420:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332809 |
| 2026-08-0420:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-332773 |
| 2026-06-0420:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-257423 |
| 2026-05-0520:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206396 |
| 2026-05-0520:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-206345 |
| 2026-04-2120:15 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001140361-26-015903 |
| 2026-04-0701:14 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-146025 |
| 2026-03-3010:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-130283 |
| 2026-03-1220:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-104147 |
| 2026-03-1220:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-104104 |
| 2025-11-0621:23 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-269652 |
| 2025-11-0621:13 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269540 |
| 2025-11-0621:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269468 |
| 2025-08-1220:20 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-178981 |
| 2025-08-1220:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-178978 |
| 2025-06-2620:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-090403 |
| 2025-05-3019:57 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001636587-25-000030 |
| 2025-05-2820:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-078375 |
| 2025-05-2220:49 ET | SCHEDULE 13D | Ownership report, active investor | 0001636587-25-000027 |
| 2025-05-0611:40 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-063970 |
| 2025-05-0611:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063969 |
| 2025-04-1620:23 ET | DEF 14A | Proxy statementPeriod 2025-05-27 | 0001140361-25-014183 |
| 2025-03-1020:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036306 |
| 2025-03-1020:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-036252 |
| 2025-01-2123:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-004963 |
| 2024-12-1012:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134757 |
| 2024-11-0721:05 ET | 8-K | 4.01 Change of auditor; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-123265 |
| 2024-11-0721:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123233 |
| 2024-10-2321:03 ET | S-1 | Registration statement | 0001193125-24-241926 |
| 2024-10-0823:34 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000769 |
| 2024-10-0821:26 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-234487 |
| 2024-10-0221:20 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-231281 |
| 2024-09-2011:00 ET | 8-K | 8.01 Other events | 0001193125-24-222429 |
| 2024-09-1320:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-218879 |
| 2024-08-1321:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096411 |
| 2024-08-1320:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096127 |
| 2024-05-1313:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-136785 |
| 2024-05-0820:33 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000437 |
| 2024-05-0720:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-054452 |
| 2024-05-0720:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-054442 |
| 2024-04-2610:16 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0000950170-24-048631 |
| 2024-03-2820:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-038009 |
| 2024-03-2820:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-038003 |
| 2024-02-2321:00 ET | 8-K | 2.05 Exit or disposal costs | 0000950170-24-019338 |
| 2023-12-2622:00 ET | SC 13D | Ownership report, active investor | 0001214659-23-016861 |
| 2023-12-1521:55 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-296752 |
| 2023-12-1414:26 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events | 0001193125-23-295039 |
| 2023-11-1321:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062910 |
| 2023-11-1321:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062888 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.